Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.

Treating IFD is resource intensive, often requires intensive care and implies high rates of in-hospital mortality. Our study emphasises the high hospital treatment costs and thus the need for reimbursement systems to enable live-saving costly treatments.